Francesco Maura
@FrancescoMaura4
Assistant Member, @MSKCancerCenter , @MSK_DeptOfMed, #NYC, myeloma, #mmsm, genomics, #WGS, #haematology
🚨 New paper in @NatureGenet ! How does cancer chemotherapy reshape the HSC landscape and drive the evolution of therapy-related myeloid neoplasms? We uncovered this process through single-colony WGS! See the full paper here! nature.com/articles/s4158…
Important new research from one of our Cancer Grand Challenge’s teams could help to improve cancer treatment choices in the future. While many cancers can now be targeted using precision therapies, chemotherapy remains a key way to treat some cancers and saves many lives every…
Today, patients with multiple myeloma, and those with precursor conditions, are prognosticated by measuring tumor burden and identifying whether malignant cPCs carry cytogenetic abnormalities associated with high-risk disease. ow.ly/Cy8150WhFO2 #lymphoidneoplasia
The lab and the myeloma team at @MSKCancerCenter are very excited to welcome my friend and long term collaborator @BachisioZic and to host the rising star @hollyleeYJ for the rest of 2025 as visiting scientist @szusmani #mmsm
It was fun to work with @RossFirestone in writing this editorial for @BloodPortfolio #Blood "More than myeloma: the trouble with “normal” plasma cells", on the recent article from @nickbolli @matteoclaudio84 sciencedirect.com/science/articl… @MSKCancerCenter @MSK_DeptOfMed #mmsm
Lymphoma Microenvironment Archetype Profiles (LymphoMAPs). Just presented by @dgermain21 at #18icml @icmlugano, now available online in Cancer Cell. #lmsm @washumedicine @MDAndersonNews. cell.com/cancer-cell/fu…
3 postdoctoral positions (1 comp, 2 experimental) available @ BaslanLab/Penn. We employ computation & functional biology to develop novel therapeutics, diagnostics & prognostic markers. Further detail below. Please share w/ trainees, colleagues & friends. nature.com/naturecareers/…
Biallelic Antigen Escape is a Mechanism of Resistance to Anti-CD38 Antibodies in MM - @FrancescoMaura4 @BloodPortfolio @BenDiamondMD @lbaughn @MayoMyeloma @Rfonsi1 @NBahlis @myelomaMD @RaabMarc oncodaily.com/science/anti-c… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter…
#EHA2025 CTC session in myeloma and amyloidosis #mmsm CTCs are fighting for a sit on the table of routine staging of these patients. Congrats Ioannis Kostopoulos, @juanjogrcs @LucaBertamini @DZihala @TomasJelinekMD @Dagostino_MD
Our lab fantastic postdoc @juanjogrcs will present today our study on CTC in multiple myeloma @mmsm. Several relevant findings by linking WGS, RNAseq and CTC. Great collaboration with @TomasJelinekMD @BenDiamondMD @szusmani @MSKCancerCenter @OsuChsd @univmiami @theMMRF #mmsm
Almost ready to present our work about #CTCs at #EHA2025, come to learn about how #liquidbiopsies can change the paradigm of #mmsm!
#Myeloma Paper of the Day: Biallelic antigen escape may be mechanism of resistance to anti-CD38 antibodies; L153H & C275Y decreased binding affinity & ADCC of daratumumab & isatuximab while a 3rd, R140G, conferred selective resistance to dara only: pubmed.ncbi.nlm.nih.gov/40493883/. #mmsm
It was a great experience and honor to present during my 1st IMWG in my hometown Milan 🇮🇹 our new data on MGUS/SMM progression #mmsm #wgs
We’re off to an amazing start with @FrancescoMaura4 walking us through the nuts and bolts of progression from MGUS to myeloma along with @VincentRK @mvmateos @IrenemGhobrial @thanosdimop. @IMFmyeloma #mmsm
Just out! New IMS/ IMWG Definition of High Risk Myeloma. @JCO_ASCO #ASCO25 @Myeloma_Society @IMFmyeloma @NikhilMunshiMD @mvmateos @SagarLonialMD @szusmani @NoopurRajeMD